# Manisha H. Shah

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/manisha-h-shah/

## Facts

| Field | Value |
| --- | --- |
| Citations | 34,430 |
| Field | Neuroendocrine Tumor Research Advances |
| h-index | 64 |
| i10-index | 163 |
| Last Known Institution | The Ohio State University Wexner Medical Center |
| OpenAlex ID | https://openalex.org/A5035552610 |
| ORCID iD | https://orcid.org/0000-0002-6453-2044 |
| Works | 321 |

## Researcher papers

- [Everolimus for Advanced Pancreatic Neuroendocrine Tumors](https://scholariq.org/papers/everolimus-for-advanced-pancreatic-neuroendocrine-tumors/)
- [Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma](https://scholariq.org/papers/revised-american-thyroid-association-guidelines-for-the-management-of-medullary/)
- [Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer](https://scholariq.org/papers/lenvatinib-versus-placebo-in-radioiodine-refractory-thyroid-cancer/)
- [Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer](https://scholariq.org/papers/efficacy-of-selpercatinib-in-i-ret-i-fusion-positive-non-small-cell-lung-cancer/)
- [Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers](https://scholariq.org/papers/efficacy-of-selpercatinib-in-i-ret-i-altered-thyroid-cancers/)
- [Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial](https://scholariq.org/papers/daily-oral-everolimus-activity-in-patients-with-metastatic-pancreatic/)
- [Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/neuroendocrine-and-adrenal-tumors-version-2-2021-nccn-clinical-practice/)
- [NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018](https://scholariq.org/papers/nccn-guidelines-insights-neuroendocrine-and-adrenal-tumors-version-2-2018/)

## Researcher topics

- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Thyroid Cancer Diagnosis and Treatment](https://scholariq.org/topics/thyroid-cancer-diagnosis-and-treatment-2/)
- [Neuroblastoma Research and Treatments](https://scholariq.org/topics/neuroblastoma-research-and-treatments/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Researcher university

- [The Ohio State University Wexner Medical Center](https://scholariq.org/institutions/the-ohio-state-university-wexner-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.